JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200
JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200
Price:
10.06 CNY
0.4%
Market Closed
Updated:
May 29, 2024
Balance Sheet
Balance Sheet Decomposition
JiangSu WuZhong Pharmaceutical Development Co Ltd
JiangSu WuZhong Pharmaceutical Development Co Ltd
| Current Assets | 3B |
| Cash & Short-Term Investments | 1.6B |
| Receivables | 1.2B |
| Other Current Assets | 230.3m |
| Non-Current Assets | 1.3B |
| Long-Term Investments | 794.6m |
| PP&E | 262.8m |
| Intangibles | 236.3m |
| Other Non-Current Assets | 31.9m |
| Current Liabilities | 2.4B |
| Accounts Payable | 275.7m |
| Accrued Liabilities | 36.9m |
| Short-Term Debt | 1.6B |
| Other Current Liabilities | 449.4m |
| Non-Current Liabilities | 203.9m |
| Long-Term Debt | 140.7m |
| Other Non-Current Liabilities | 63.2m |
Balance Sheet
JiangSu WuZhong Pharmaceutical Development Co Ltd
JiangSu WuZhong Pharmaceutical Development Co Ltd
Currency: CNY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
456
|
617
|
848
|
770
|
490
|
589
|
646
|
1 091
|
1 323
|
1 602
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 091
|
1 323
|
1 602
|
|
| Cash Equivalents |
456
|
616
|
847
|
769
|
490
|
589
|
646
|
0
|
0
|
0
|
|
| Short-Term Investments |
2
|
1
|
1
|
1
|
390
|
261
|
120
|
170
|
171
|
0
|
|
| Total Receivables |
484
|
635
|
574
|
664
|
568
|
892
|
1 259
|
790
|
942
|
1 169
|
|
| Accounts Receivables |
252
|
270
|
333
|
365
|
458
|
542
|
687
|
760
|
859
|
949
|
|
| Other Receivables |
232
|
365
|
240
|
300
|
110
|
350
|
572
|
30
|
83
|
220
|
|
| Inventory |
1 820
|
1 730
|
1 249
|
922
|
1 058
|
215
|
155
|
126
|
113
|
107
|
|
| Other Current Assets |
304
|
446
|
397
|
163
|
203
|
70
|
501
|
507
|
181
|
123
|
|
| Total Current Assets |
3 066
|
3 428
|
3 068
|
2 520
|
2 709
|
2 027
|
2 680
|
2 684
|
2 730
|
3 001
|
|
| PP&E Net |
470
|
450
|
802
|
912
|
1 001
|
1 018
|
295
|
254
|
232
|
263
|
|
| PP&E Gross |
470
|
450
|
802
|
912
|
1 001
|
1 018
|
295
|
254
|
232
|
263
|
|
| Accumulated Depreciation |
246
|
293
|
413
|
473
|
535
|
596
|
483
|
429
|
445
|
458
|
|
| Intangible Assets |
133
|
138
|
194
|
194
|
238
|
261
|
156
|
192
|
204
|
236
|
|
| Goodwill |
0
|
0
|
380
|
380
|
13
|
13
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
|
| Long-Term Investments |
338
|
213
|
719
|
520
|
586
|
547
|
563
|
621
|
730
|
795
|
|
| Other Long-Term Assets |
13
|
14
|
76
|
108
|
72
|
54
|
10
|
7
|
11
|
29
|
|
| Other Assets |
0
|
0
|
380
|
380
|
13
|
13
|
0
|
0
|
0
|
0
|
|
| Total Assets |
4 019
N/A
|
4 242
+6%
|
5 240
+24%
|
4 635
-12%
|
4 618
0%
|
3 920
-15%
|
3 704
-6%
|
3 758
+1%
|
3 910
+4%
|
4 327
+11%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
468
|
403
|
399
|
290
|
343
|
284
|
240
|
132
|
240
|
276
|
|
| Accrued Liabilities |
41
|
4
|
53
|
57
|
53
|
33
|
42
|
38
|
31
|
37
|
|
| Short-Term Debt |
1 406
|
1 054
|
1 089
|
731
|
929
|
938
|
1 051
|
1 157
|
1 395
|
1 617
|
|
| Current Portion of Long-Term Debt |
30
|
161
|
0
|
0
|
1
|
22
|
20
|
63
|
33
|
40
|
|
| Other Current Liabilities |
495
|
404
|
442
|
400
|
756
|
135
|
242
|
306
|
157
|
410
|
|
| Total Current Liabilities |
2 439
|
2 025
|
1 984
|
1 478
|
2 082
|
1 413
|
1 595
|
1 696
|
1 856
|
2 379
|
|
| Long-Term Debt |
340
|
426
|
88
|
88
|
87
|
115
|
229
|
168
|
165
|
141
|
|
| Deferred Income Tax |
0
|
0
|
121
|
74
|
4
|
3
|
0
|
6
|
6
|
9
|
|
| Minority Interest |
148
|
160
|
29
|
12
|
16
|
5
|
4
|
22
|
20
|
17
|
|
| Other Liabilities |
101
|
89
|
79
|
63
|
37
|
26
|
27
|
12
|
59
|
37
|
|
| Total Liabilities |
3 029
N/A
|
2 701
-11%
|
2 300
-15%
|
1 715
-25%
|
2 226
+30%
|
1 562
-30%
|
1 856
+19%
|
1 903
+3%
|
2 106
+11%
|
2 583
+23%
|
|
| Equity | |||||||||||
| Common Stock |
624
|
670
|
722
|
722
|
722
|
712
|
712
|
712
|
712
|
712
|
|
| Retained Earnings |
346
|
383
|
443
|
551
|
225
|
289
|
217
|
222
|
298
|
370
|
|
| Additional Paid In Capital |
20
|
520
|
1 445
|
1 446
|
1 445
|
1 403
|
1 403
|
1 403
|
1 404
|
1 412
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Treasury Stock |
0
|
31
|
18
|
9
|
0
|
40
|
40
|
40
|
15
|
10
|
|
| Other Equity |
0
|
0
|
348
|
209
|
0
|
7
|
11
|
0
|
0
|
0
|
|
| Total Equity |
990
N/A
|
1 542
+56%
|
2 940
+91%
|
2 920
-1%
|
2 392
-18%
|
2 358
-1%
|
1 848
-22%
|
1 855
+0%
|
1 804
-3%
|
1 744
-3%
|
|
| Total Liabilities & Equity |
4 019
N/A
|
4 242
+6%
|
5 240
+24%
|
4 635
-12%
|
4 618
0%
|
3 920
-15%
|
3 704
-6%
|
3 758
+1%
|
3 910
+4%
|
4 327
+11%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
624
|
665
|
719
|
722
|
722
|
705
|
705
|
705
|
705
|
704
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
